Related Experiment Video

Updated: Aug 24, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Stroke prevention, blood cholesterol, and statins

Pierre Amarenco1, Philippa Lavallée, Pierre-Jean Touboul

  • 1Department of Neurology and Stroke Centre, Bichat-Claude Bernard University Hospital and Medical School, Denis Diderot University-Paris VII, France. amerenco@ccr.jussieu.fr

The Lancet. Neurology
|April 22, 2004
PubMed

Insights

Statins significantly reduce stroke incidence in patients with coronary heart disease, preventing 0.9% of strokes. However, their effectiveness in preventing recurrent strokes requires further investigation.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Pharmacology

Background:

  • Stroke risk escalates with age, disproportionately affecting the elderly who often have co-existing coronary heart disease.
  • Existing epidemiological data present an unclear link between cholesterol levels and overall stroke risk.
  • Large-scale statin trials demonstrate a significant reduction in stroke incidence among patients with established or high cardiovascular risk.

Purpose of the Study:

  • To review the effects of statins on stroke incidence and recurrence.
  • To explore potential mechanisms behind statin action on stroke.
  • To discuss optimal treatment strategies for stroke prevention.

Main Methods:

  • Analysis of large, long-term statin trials involving over 70,000 patients.
  • Review of studies examining statin effects on major coronary events and stroke recurrence.
  • Discussion of potential mechanisms of action and treatment strategies.

Main Results:

  • Statin trials show a 21% relative and 0.9% absolute risk reduction in stroke incidence.
  • Statin therapy prevents approximately nine strokes per 1000 patients over five years in coronary heart disease populations.
  • Evidence suggests statins may not effectively lower stroke recurrence in patients with a prior stroke.

Conclusions:

  • Statins are effective in reducing initial stroke incidence, particularly in high-risk cardiovascular patients.
  • The role of statins in preventing recurrent strokes warrants further investigation.
  • A global cardiovascular risk-based treatment approach may be the most effective strategy for stroke prevention.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...